SCHEMBL3605823

SCHEMBL3605823

O=C(Cn1cnc2cc(Cl)c(Cl)cc21)NCCNCC1CCCCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.42
ALDH1A1 P00352 2/20 0.42
MITF O75030 1/20 0.42
LMNA P02545 1/20 0.42
MAPT P10636 1/20 0.42
RECQL P46063 1/20 0.42
RAB9A P51151 1/20 0.42
MDM2 Q00987 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CCNE1 P24864 1/20 0.41
CDK2 P24941 1/20 0.41
CDK5 Q00535 1/20 0.41
ENPP2 Q13822 8/20 0.41
PRPS1 P60891 2/20 0.39
POLB P06746 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
HPGD P15428 2/20 0.38
TSHR P16473 1/20 0.38
GRIN2B Q13224 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3597093 0.88 BACE1 (0.47) HTTALDH1A1LMNARECQLRAB9A
SCHEMBL5345354 0.83 TRPA1 (0.44) HTTALDH1A1LMNARAB9ASMN1; SMN2
SCHEMBL3602189 0.83 HPGD (0.43) ALDH1A1LMNAMAPTRAB9ASMN1; SMN2
SCHEMBL5367271 0.81 MTNR1A (0.53) HTTALDH1A1SMN1; SMN2POLBKMT2A
SCHEMBL3606208 0.81 TP53 (0.44) HTTALDH1A1MAPTSMN1; SMN2POLB
SCHEMBL3605821 0.81 CCNE1 (0.43) MAPTSMN1; SMN2CCNE1CDK2CDK5
SCHEMBL3599702 0.80 GRIN2B (0.41) ALDH1A1LMNARAB9ACCNE1CDK2
SCHEMBL3605623 0.77 TRPA1 (0.43) LMNARECQLSMN1; SMN2POLBMEN1
SCHEMBL3597269 0.77 ENPP2 (0.45) HTTLMNARECQLSMN1; SMN2ENPP2
SCHEMBL3608393 0.75 PRPS1 (0.41) HTTALDH1A1MITFLMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7807704-B2 Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2 CHEMOCENTRYX, INC. (US) 2010-10-05 US disclosed
US-20070275965-A1 CXCR4 modulators CHEMOCENTRYX, INC. (US) 2007-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275965-A1 CXCR4 modulators CXCL12, CXCR4, CXCR1 HTT 1553/4885ALDH1A1 662/4885MITF 88/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.